The Effect of Buteyko Breathing Technique on Asthma Control and Quality of Life in Children With Asthma
1 other identifier
interventional
45
1 country
2
Brief Summary
In this study, the effect of buteyko breathing technique applied in children aged 7-12 years with asthma disease on asthma control and quality of life is examined. Asthma is a serious global health problem affecting all age groups. In studies conducted with the ISSAC (International study of asthma and allergies in childhood) method, the prevalence of asthma varies between 4-23% in developed populations. In childhood prevalence studies in our country, the cumulative asthma prevalence was found to be between 13.7% and 15.3%. There are personal and environmental factors of genetic origin that cause asthma. Its prevalence is increasing in many countries, particularly among children. Asthma is a chronic inflammatory disease of the airways in which many cells and cellular elements play a role. It is seen with recurrent episodes of wheezing, coughing and shortness of breath due to lower airway obstruction and chronic inflammation. Nurses will contribute to the protection and improvement of patients' health and well-being, to control asthma, to increase the quality of life, and to reduce health care expenditures, thanks to the hands-on training they will give to patients with asthma. Keyword: Asthma, Quality of Life, Asthma Control
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2023
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 3, 2023
CompletedFirst Posted
Study publicly available on registry
March 31, 2023
CompletedStudy Start
First participant enrolled
October 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 15, 2024
CompletedJanuary 22, 2025
January 1, 2025
5 months
February 3, 2023
January 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Asthma Control Test for Children (CISAT)
Asthma control test is the most used test today, is easily understood by patients and their families, and is an important test that shows whether asthma is good or bad. AKT is a questionnaire consisting of 5 questions. It is a 5-item asthma control questionnaire that defines children whose asthma is not adequately controlled. The ACT is scored on a scale of 1-5 for each question. Patients rate each question between one and five points. The total score of the five questions forms the test result. If the total score is 25, it is considered as full control, 24-20 as partial control, and ≤19 as not under control
at the end of 4 weeks
Secondary Outcomes (1)
The Scale of Quality of Life in Children with Asthma ÇAYKÖ
at the end of 4 weeks
Study Arms (2)
BUTEYKO RESPIRATORY TECHNIQUE APPLIED GROUP
EXPERIMENTALThis group consists of children between the ages of 7 and 12 who are being treated for asthma. Children with written and verbal consent from their families will be filled with a personal information form, asthma control test and quality of life scale for children. The standard care and treatment of the asthmatic child included in the experimental group will be continued without any intervention. The child included in this group will be taught the Buteyko Breathing Technique (BST) via a smart phone, and the training video will be watched and taught. The training video will be watched on the official site that explains BST in a practical way. The video will be downloaded to the phone of the child or parent using a smartphone at home, for researchers to apply later at home. The participant will continue to apply this technique at home for 10 minutes in addition to his treatment when he needs a bronchodilator in the morning and evening for 4 weeks.
GROUP WITH STANDARD CARE AND TREATMENT
NO INTERVENTIONThis group consists of children aged 7-12 years with asthma who continue to receive standard care and treatment. Children with written and verbal consent from their families will be filled with a personal information form, asthma control test and quality of life scale for children. Asthma control test and quality of life scale for the child with asthma will be administered to the participant who continues the standard treatment and care for 4 weeks. After the research data are collected, the children in the control group will be shown a video explaining the BST in a practical way.
Interventions
Buteyko Breathing Technique In recent years, breathing exercises have been used as one of the non-pharmacological, alternative and/or complementary approaches in the management of many chronic diseases and conditions. Buteyko Breathing Technique (BST), Russian Dr. It was developed by Konstantin Buteyko in the 1950s. Dr. Buteyko evaluates the normal respiration over carbon dioxide, the respiratory holding time used in the technique is defined as a control pause, and this value shows the body's oxygenation and carbon dioxide tolerance. BST is a technique performed only through the nose, which includes respiratory control and respiratory hold after inhalation.
Eligibility Criteria
You may qualify if:
- with asthma,
- years old with asthma
- Those who were diagnosed with asthma at least 6 months ago were treated
You may not qualify if:
- No asthma,
- Those over 12 years old and under 7 years old with asthma
- Any disease that will prevent or prevent the practice of breathing technique
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Balcali Hospital Adana
Adana, Turkey (Türkiye)
Çukurova Üniversitesi Balcalı Hastanesi
Adana, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 3, 2023
First Posted
March 31, 2023
Study Start
October 15, 2023
Primary Completion
March 15, 2024
Study Completion
September 15, 2024
Last Updated
January 22, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share